FIA
VNDA icon

FNY Investment Advisers’s Vanda Pharmaceuticals VNDA Stock Holding History

FNY Investment Advisers’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,000
Closed -$5K – 835
2024
Q2 		$5K Buy
+1,000
New +$5.17K ﹤0.01% 375
2019
Q1 		– Sell
-405
Closed -$10K – 981
2018
Q4 		$10K Buy
+405
New +$9.52K ﹤0.01% 449
2018
Q3 		– Sell
-170
Closed -$3K – 1323
2018
Q2 		$3K Buy
+170
New +$2.84K ﹤0.01% 748

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FNY Investment Advisers's VNDA Position: Q3 2024 in Review

FNY Investment Advisers sold out of Vanda Pharmaceuticals (VNDA) in Q3 2024, closing a stake of 1,000 shares — an estimated $5K sold.

FNY Investment Advisers first reported a position in VNDA in Q2 2018 and held it in 3 quarters. The position peaked at $10K in Q4 2018. 152 funds tracked by Wall St. Rank hold VNDA as of Q3 2024.

  • FNY Investment Advisers reported no remaining Vanda Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • FNY Investment Advisers sold 1,000 Vanda Pharmaceuticals shares in Q3 2024, an estimated $5K.
  • FNY Investment Advisers first reported a position in Vanda Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Vanda Pharmaceuticals position peaked at $10K in Q4 2018.
  • 152 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2024.

Based on FNY Investment Advisers's 13F filing for Q3 2024, filed 18 Oct 2024.